Literature DB >> 12072624

Discontinuous rectal cancer spread in the mesorectum and the optimal distal clearance margin in situ.

Chihiro Ono1, Keigo Yoshinaga, Masayuki Enomoto, Kenichi Sugihara.   

Abstract

PURPOSE: We examined the frequency, mode, and extent of discontinuous spread of rectal cancer in the mesorectum to determine the optimal distal clearance margin in situ.
METHODS: Forty consecutive patients with rectal cancer undergoing locally curative resection were studied prospectively. Discontinuous cancer spread in the mesorectum and the extent of distal spread was examined microscopically. A tissue shrinkage ratio comparing the distal clearance margin measured before transection to that measured after fixation in each case, was used to convert microscopically measured extent of distal spread to extent in situ.
RESULTS: Discontinuous cancer spread in the mesorectum was observed in 17 cases (43 percent); lymph node metastasis in 15 cases (38 percent) and small deposits other than nodal metastases in 8 cases (20 percent). Distal cancer spread (either intramural or mesorectal) was observed in 6 cases (15 percent). The mean distal clearance margin before transection and after fixation was 3.2 cm and 2 cm, respectively. The mean tissue shrinkage ratio was 60 percent. The maximum extent of microscopic distal spread and adjusted distal spread in situ were 20 and 24 mm, respectively.
CONCLUSIONS: Excising the mesorectum with fascia propria circumferentially intact is essential for rectal surgery. The optimal distal clearance margin for the rectal wall as well as the mesorectum in situ can be reduced to 3 cm with a right angle.

Entities:  

Mesh:

Year:  2002        PMID: 12072624     DOI: 10.1007/s10350-004-6290-1

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  26 in total

1.  Surgery of rectal cancer: still not a science.

Authors:  Federico Bozzetti
Journal:  Int J Colorectal Dis       Date:  2003-10-03       Impact factor: 2.571

2.  Using p53-immunostained large specimens to determine the distal intramural spread margin of rectal cancer.

Authors:  Zhi-Zhong Pan; De-Sen Wan; Chang-Qing Zhang; Jian-Yong Shao; Li-Ren Li; Gong Chen; Zhi-Wei Zhou; Fu-Long Wang
Journal:  World J Gastroenterol       Date:  2006-03-14       Impact factor: 5.742

3.  Comment on: a clinicopathological investigation of "tumor nodules" in colorectal cancer.

Authors:  Giacomo Puppa; Tiziana Perin; Vincenzo Canzonieri
Journal:  Surg Today       Date:  2006       Impact factor: 2.549

4.  Microscopic spread of low rectal cancer in regions of the mesorectum: detailed pathological assessment with whole-mount sections.

Authors:  Zhao Wang; Zongguang Zhou; Cun Wang; Gaoping Zhao; Youdai Chen; Hongkai Gao; Xuelian Zheng; Rong Wang; Daiyun Chen
Journal:  Int J Colorectal Dis       Date:  2004-12-22       Impact factor: 2.571

5.  Effect of preoperative chemotherapy on distal spread of low rectal cancer located close to the anus.

Authors:  Akihiro Kondo; Yuichiro Tsukada; Motohiro Kojima; Yuji Nishizawa; Takeshi Sasaki; Yasuyuki Suzuki; Masaaki Ito
Journal:  Int J Colorectal Dis       Date:  2018-09-13       Impact factor: 2.571

6.  The clinical significance of distal spread differs according to the primary tumor location in rectal cancer.

Authors:  Kaoru Abe; Yoshifumi Shimada; Hidehito Oyanagi; Ryoma Yagi; Masato Nakano; Hitoshi Kameyama; Hitoshi Nogami; Satoshi Maruyama; Yasumasa Takii; Toshifumi Wakai
Journal:  Surg Today       Date:  2019-09-30       Impact factor: 2.549

Review 7.  Distal dissection in total mesorectal excision, and preoperative chemoradiotherapy and lateral lymph node dissection for rectal cancer.

Authors:  Jin-ichi Hida; Kiyotaka Okuno; Tadao Tokoro
Journal:  Surg Today       Date:  2013-12-22       Impact factor: 2.549

8.  [Problems in the treatment of upper rectal carcinoma].

Authors:  T Junginger; P Hermanek
Journal:  Chirurg       Date:  2008-04       Impact factor: 0.955

9.  In vivo lymph node mapping and pattern of metastasis spread in locally advanced mid/low rectal cancer after neoadjuvant chemoradiotherapy.

Authors:  E Farinella; L Viganò; M C Fava; M Mineccia; F Bertolino; L Capussotti
Journal:  Int J Colorectal Dis       Date:  2013-07-23       Impact factor: 2.571

10.  Microscopic spread of low rectal cancer in regions of mesorectum: pathologic assessment with whole-mount sections.

Authors:  Zhao Wang; Zong-Guang Zhou; Cun Wang; Gao-Ping Zhao; You-Dai Chen; Hong-Kai Gao; Xue-Lian Zheng; Rong Wang; Dai-Yun Chen; Wei-Ping Liu
Journal:  World J Gastroenterol       Date:  2004-10-15       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.